Synergistic Cytotoxic Effects of Bortezomib and CK2 Inhibitor CX-4945 in Acute LymphOblastic Leukemia: Turning Off the Prosurvival ER Chaperone BIP/Grp78 and Turning on the Pro-apoptotic NF-κB

McCubrey, James A.2022-01-312022-01-312016-01-121949-2553http://hdl.handle.net/10342/9588en-USSynergistic Cytotoxic Effects of Bortezomib and CK2 Inhibitor CX-4945 in Acute LymphOblastic Leukemia: Turning Off the Prosurvival ER Chaperone BIP/Grp78 and Turning on the Pro-apoptotic NF-κBArticle10.18632/oncotarget.6361